Redondo, S, Garcia-Cadenas, I, Vila, A, Esquirol, A, Portos, JM, Novelli, S, Saavedra, S, Moreno, C, Garrido, A, Arguello-Tomas, M, Onate, G, Lopez-Pardo, J, Caballero, AC, Miqueleiz, S, Briones, J, Sierra, J, Sancho, G, Martino, R. Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI. EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; 111(1)DOI:10.1111/ejh.13978. PMID:37058419. IF:2.300(Q2/5D).

Bonet, M, Gonzalez, D, Baquedano, JE, Garcia, E, Altabas, M, Casas, F, Feltes, N, Ferrer, F, Foro, P, Fuentes, R, Galdeano, M, Gomez, D, Henriquez, I, Jove, J, Lozano, J, Maldonado, X, Mases, J, Membrive, I, Paredes, S, Rosello, A, Sancho, G, Mira, M. Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus. Clinical & Translational Oncology. 2023; 25(4)DOI:10.1007/s12094-022-03005-4. PMID:36436177. IF:2.800(Q2/5D).

Pérez-Fidalgo J.A., Ortega E., Ponce J., Redondo A., Sevilla I., Valverde C., Verdum, JI, de Alava E., Lopez, MG, Marquina G., Sebio A.. Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS). Therapeutic Advances in Medical Oncology. 2023; 15DOI:10.1177/17588359231157645. PMID:37007636. IF:4.300(Q2/3D).

Camacho, M, Leon, X, Pujol, A, Montezuma, L, Quer, M, Garcia, J. Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy. Clinical & Translational Oncology. 2022; 24(11)DOI:10.1007/s12094-022-02870-3. PMID:35752749. IF:3.400(Q3/6D).